These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1337011)

  • 1. Effect of synthetic enantiomeric cannabinoids on platelet aggregation.
    Nathan I; Agam G; Mechoulam R; Dvilansky A; Livne AA
    Can J Physiol Pharmacol; 1992 Oct; 70(10):1305-8. PubMed ID: 1337011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid.
    Feigenbaum JJ; Richmond SA; Weissman Y; Mechoulam R
    Eur J Pharmacol; 1989 Oct; 169(1):159-65. PubMed ID: 2557222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabimimetic activity of novel enantiomeric, benzofuran cannabinoids.
    Mechoulam R; Breuer A; Järbe TU; Hiltunen AJ; Glaser R
    J Med Chem; 1990 Mar; 33(3):1037-43. PubMed ID: 2155318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomeric cannabinoids: stereospecificity of psychotropic activity.
    Mechoulam R; Feigenbaum JJ; Lander N; Segal M; Järbe TU; Hiltunen AJ; Consroe P
    Experientia; 1988 Sep; 44(9):762-4. PubMed ID: 3416993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA; Reimann S; Schrör K
    Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific impairment of ADP-induced platelet aggregation by cannabinoids.
    Nathan I; Dvilansky A; Lazarowitz J; Lander N; Livne A
    Int J Tissue React; 1986; 8(3):193-8. PubMed ID: 3781759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211.
    Nadler V; Mechoulam R; Sokolovsky M
    Brain Res; 1993 Sep; 622(1-2):79-85. PubMed ID: 8242387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and platelet aggregation inhibition activity of a series of enantiomeric bicyclo[3.2.0]heptane-6-oximinoacetic acids (1).
    O-Yang C; Kertesz DJ; Kluge AF; Kuenzler P; Li TT; Marx MM; Bruno JJ; Chang LF
    Prostaglandins; 1984 Jun; 27(6):851-63. PubMed ID: 6484210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-delta 6- tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain.
    Nadler V; Mechoulam R; Sokolovsky M
    Neurosci Lett; 1993 Nov; 162(1-2):43-5. PubMed ID: 8121633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid.
    Beilin M; Neumann R; Belkin M; Green K; Bar-Ilan A
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):217-30. PubMed ID: 10872919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation.
    Formukong EA; Evans AT; Evans FJ
    J Pharm Pharmacol; 1989 Oct; 41(10):705-9. PubMed ID: 2575149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid enantiomer action on the cytoarchitecture.
    Wilson RG; Tahir SK; Mechoulam R; Zimmerman S; Zimmerman AM
    Cell Biol Int; 1996 Feb; 20(2):147-57. PubMed ID: 8935159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM; Hall DA; Nieman CJ
    Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenine, an inhibitor of platelet aggregation, from the leaves of Cassia alata.
    Moriyama H; Iizuka T; Nagai M; Hoshi K
    Biol Pharm Bull; 2003 Sep; 26(9):1361-4. PubMed ID: 12951489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker.
    Feigenbaum JJ; Bergmann F; Richmond SA; Mechoulam R; Nadler V; Kloog Y; Sokolovsky M
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9584-7. PubMed ID: 2556719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of ADP-induced platelet aggregation by hashish components.
    Levy R; Schurr A; Nathan I; Dvilanski A; Livne A
    Thromb Haemost; 1976 Dec; 36(3):634-40. PubMed ID: 1037158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice.
    Collins DR; Pertwee RG; Davies SN
    Eur J Pharmacol; 1994 Jul; 259(3):R7-8. PubMed ID: 7982446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogues of diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) as potential anti-platelet-aggregation agents.
    Zamecnik PC; Kim B; Gao MJ; Taylor G; Blackburn GM
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2370-3. PubMed ID: 1549600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modulating effects of adenosine on the process of human platelet activation].
    Prokudin VIu; Melkova OM; Karaulov AV; Porodenko NV
    Biull Eksp Biol Med; 1992 Jun; 113(6):606-8. PubMed ID: 1446028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trapidil decreases the aggregation of platelets from heart transplant recipients ex vivo.
    Jovin IS; Taborski U; Szalay Z; Friedel A; Segieth I; Jovin A; Heidinger K; Schreiner K; Frass O; Klövekorn WP; Müller-Berghaus G
    Transplant Proc; 2006 Jun; 38(5):1523-5. PubMed ID: 16797349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.